On June 30, 2023, the Centers for Medicare and Medicaid Services (CMS) released its much-anticipated final guidance ("Final Guidance") for the Medicare Drug Price Negotiation Program.
After much anticipation, the EU Commission's proposal for a regulation on plants developed using New Genomic Techniques (NGTs) is now under consideration. For an overview of the EU proposal.